 | • レポートコード：QFJ1-4514 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、分子診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、DNAシーケンシング、NGS）、用途別市場規模（診断研究所、研究所、学術研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・分子診断＆治療の市場動向 ・企業の競争状況、市場シェア ・分子診断＆治療の種類別市場規模と予測2016-2027（PCR、DNAシーケンシング、NGS） ・分子診断＆治療の用途別市場規模と予測2016-2027（診断研究所、研究所、学術研究所） ・分子診断＆治療の北米市場規模2016-2027（アメリカ、カナダ） ・分子診断＆治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・分子診断＆治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・分子診断＆治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・分子診断＆治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Agilent Technologies、Becton, Dickinson and Company、Biomérieux Sa、Danaher Corporation、Diasorin、Grifols、Hologic、Illumina、Qiagen、Roche Diagnostics、Siemens AG、Thermo Fisher Scientific） ・結論 |
Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.
Market Analysis and Insights: Global Molecular Diagnosis and Therapy Market
The global Molecular Diagnosis and Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnosis and Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnosis and Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnosis and Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnosis and Therapy market.
Global Molecular Diagnosis and Therapy Scope and Market Size
Molecular Diagnosis and Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnosis and Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PCR
DNA Sequencing
NGS
Segment by Application
Diagnostic Laboratories
Research & Academic Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Biomérieux Sa
Danaher Corporation
Diasorin
Grifols
Hologic
Illumina
Qiagen
Roche Diagnostics
Siemens AG
Thermo Fisher Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 DNA Sequencing
1.2.4 NGS
1.3 Market by Application
1.3.1 Global Molecular Diagnosis and Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic Laboratories
1.3.3 Research & Academic Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnosis and Therapy Market Perspective (2016-2027)
2.2 Molecular Diagnosis and Therapy Growth Trends by Regions
2.2.1 Molecular Diagnosis and Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Diagnosis and Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Diagnosis and Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Diagnosis and Therapy Industry Dynamic
2.3.1 Molecular Diagnosis and Therapy Market Trends
2.3.2 Molecular Diagnosis and Therapy Market Drivers
2.3.3 Molecular Diagnosis and Therapy Market Challenges
2.3.4 Molecular Diagnosis and Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnosis and Therapy Players by Revenue
3.1.1 Global Top Molecular Diagnosis and Therapy Players by Revenue (2016-2021)
3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnosis and Therapy Revenue
3.4 Global Molecular Diagnosis and Therapy Market Concentration Ratio
3.4.1 Global Molecular Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis and Therapy Revenue in 2020
3.5 Molecular Diagnosis and Therapy Key Players Head office and Area Served
3.6 Key Players Molecular Diagnosis and Therapy Product Solution and Service
3.7 Date of Enter into Molecular Diagnosis and Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnosis and Therapy Breakdown Data by Type
4.1 Global Molecular Diagnosis and Therapy Historic Market Size by Type (2016-2021)
4.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2022-2027)
5 Molecular Diagnosis and Therapy Breakdown Data by Application
5.1 Global Molecular Diagnosis and Therapy Historic Market Size by Application (2016-2021)
5.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Molecular Diagnosis and Therapy Market Size (2016-2027)
6.2 North America Molecular Diagnosis and Therapy Market Size by Type
6.2.1 North America Molecular Diagnosis and Therapy Market Size by Type (2016-2021)
6.2.2 North America Molecular Diagnosis and Therapy Market Size by Type (2022-2027)
6.2.3 North America Molecular Diagnosis and Therapy Market Size by Type (2016-2027)
6.3 North America Molecular Diagnosis and Therapy Market Size by Application
6.3.1 North America Molecular Diagnosis and Therapy Market Size by Application (2016-2021)
6.3.2 North America Molecular Diagnosis and Therapy Market Size by Application (2022-2027)
6.3.3 North America Molecular Diagnosis and Therapy Market Size by Application (2016-2027)
6.4 North America Molecular Diagnosis and Therapy Market Size by Country
6.4.1 North America Molecular Diagnosis and Therapy Market Size by Country (2016-2021)
6.4.2 North America Molecular Diagnosis and Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnosis and Therapy Market Size (2016-2027)
7.2 Europe Molecular Diagnosis and Therapy Market Size by Type
7.2.1 Europe Molecular Diagnosis and Therapy Market Size by Type (2016-2021)
7.2.2 Europe Molecular Diagnosis and Therapy Market Size by Type (2022-2027)
7.2.3 Europe Molecular Diagnosis and Therapy Market Size by Type (2016-2027)
7.3 Europe Molecular Diagnosis and Therapy Market Size by Application
7.3.1 Europe Molecular Diagnosis and Therapy Market Size by Application (2016-2021)
7.3.2 Europe Molecular Diagnosis and Therapy Market Size by Application (2022-2027)
7.3.3 Europe Molecular Diagnosis and Therapy Market Size by Application (2016-2027)
7.4 Europe Molecular Diagnosis and Therapy Market Size by Country
7.4.1 Europe Molecular Diagnosis and Therapy Market Size by Country (2016-2021)
7.4.2 Europe Molecular Diagnosis and Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnosis and Therapy Market Size (2016-2027)
8.2 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnosis and Therapy Market Size (2016-2027)
9.2 Latin America Molecular Diagnosis and Therapy Market Size by Type
9.2.1 Latin America Molecular Diagnosis and Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Diagnosis and Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Diagnosis and Therapy Market Size by Type (2016-2027)
9.3 Latin America Molecular Diagnosis and Therapy Market Size by Application
9.3.1 Latin America Molecular Diagnosis and Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Diagnosis and Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Diagnosis and Therapy Market Size by Application (2016-2027)
9.4 Latin America Molecular Diagnosis and Therapy Market Size by Country
9.4.1 Latin America Molecular Diagnosis and Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Diagnosis and Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnosis and Therapy Market Size (2016-2027)
10.2 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Molecular Diagnosis and Therapy Introduction
11.2.4 Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.2.5 Agilent Technologies Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Introduction
11.3.4 Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 Biomérieux Sa
11.4.1 Biomérieux Sa Company Details
11.4.2 Biomérieux Sa Business Overview
11.4.3 Biomérieux Sa Molecular Diagnosis and Therapy Introduction
11.4.4 Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.4.5 Biomérieux Sa Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Molecular Diagnosis and Therapy Introduction
11.5.4 Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.5.5 Danaher Corporation Recent Development
11.6 Diasorin
11.6.1 Diasorin Company Details
11.6.2 Diasorin Business Overview
11.6.3 Diasorin Molecular Diagnosis and Therapy Introduction
11.6.4 Diasorin Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.6.5 Diasorin Recent Development
11.7 Grifols
11.7.1 Grifols Company Details
11.7.2 Grifols Business Overview
11.7.3 Grifols Molecular Diagnosis and Therapy Introduction
11.7.4 Grifols Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.7.5 Grifols Recent Development
11.8 Hologic
11.8.1 Hologic Company Details
11.8.2 Hologic Business Overview
11.8.3 Hologic Molecular Diagnosis and Therapy Introduction
11.8.4 Hologic Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.8.5 Hologic Recent Development
11.9 Illumina
11.9.1 Illumina Company Details
11.9.2 Illumina Business Overview
11.9.3 Illumina Molecular Diagnosis and Therapy Introduction
11.9.4 Illumina Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.9.5 Illumina Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnosis and Therapy Introduction
11.10.4 Qiagen Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.10.5 Qiagen Recent Development
11.11 Roche Diagnostics
11.11.1 Roche Diagnostics Company Details
11.11.2 Roche Diagnostics Business Overview
11.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Introduction
11.11.4 Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.11.5 Roche Diagnostics Recent Development
11.12 Siemens AG
11.12.1 Siemens AG Company Details
11.12.2 Siemens AG Business Overview
11.12.3 Siemens AG Molecular Diagnosis and Therapy Introduction
11.12.4 Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.12.5 Siemens AG Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Introduction
11.13.4 Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2016-2021)
11.13.5 Thermo Fisher Scientific Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of DNA Sequencing
Table 4. Key Players of NGS
Table 5. Global Molecular Diagnosis and Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Molecular Diagnosis and Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Molecular Diagnosis and Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Molecular Diagnosis and Therapy Market Share by Regions (2016-2021)
Table 9. Global Molecular Diagnosis and Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Molecular Diagnosis and Therapy Market Share by Regions (2022-2027)
Table 11. Molecular Diagnosis and Therapy Market Trends
Table 12. Molecular Diagnosis and Therapy Market Drivers
Table 13. Molecular Diagnosis and Therapy Market Challenges
Table 14. Molecular Diagnosis and Therapy Market Restraints
Table 15. Global Molecular Diagnosis and Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Molecular Diagnosis and Therapy Market Share by Players (2016-2021)
Table 17. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis and Therapy as of 2020)
Table 18. Ranking of Global Top Molecular Diagnosis and Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Molecular Diagnosis and Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Molecular Diagnosis and Therapy Product Solution and Service
Table 22. Date of Enter into Molecular Diagnosis and Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Molecular Diagnosis and Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Molecular Diagnosis and Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Molecular Diagnosis and Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Molecular Diagnosis and Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Molecular Diagnosis and Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Molecular Diagnosis and Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Molecular Diagnosis and Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Molecular Diagnosis and Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Molecular Diagnosis and Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Molecular Diagnosis and Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Molecular Diagnosis and Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Molecular Diagnosis and Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Molecular Diagnosis and Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Molecular Diagnosis and Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Molecular Diagnosis and Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Molecular Diagnosis and Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Molecular Diagnosis and Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Molecular Diagnosis and Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Molecular Diagnosis and Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Molecular Diagnosis and Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Molecular Diagnosis and Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Molecular Diagnosis and Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Molecular Diagnosis and Therapy Product
Table 65. Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 66. Abbott Laboratories Recent Development
Table 67. Agilent Technologies Company Details
Table 68. Agilent Technologies Business Overview
Table 69. Agilent Technologies Molecular Diagnosis and Therapy Product
Table 70. Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 71. Agilent Technologies Recent Development
Table 72. Becton, Dickinson and Company Company Details
Table 73. Becton, Dickinson and Company Business Overview
Table 74. Becton, Dickinson and Company Molecular Diagnosis and Therapy Product
Table 75. Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 76. Becton, Dickinson and Company Recent Development
Table 77. Biomérieux Sa Company Details
Table 78. Biomérieux Sa Business Overview
Table 79. Biomérieux Sa Molecular Diagnosis and Therapy Product
Table 80. Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 81. Biomérieux Sa Recent Development
Table 82. Danaher Corporation Company Details
Table 83. Danaher Corporation Business Overview
Table 84. Danaher Corporation Molecular Diagnosis and Therapy Product
Table 85. Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 86. Danaher Corporation Recent Development
Table 87. Diasorin Company Details
Table 88. Diasorin Business Overview
Table 89. Diasorin Molecular Diagnosis and Therapy Product
Table 90. Diasorin Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 91. Diasorin Recent Development
Table 92. Grifols Company Details
Table 93. Grifols Business Overview
Table 94. Grifols Molecular Diagnosis and Therapy Product
Table 95. Grifols Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 96. Grifols Recent Development
Table 97. Hologic Company Details
Table 98. Hologic Business Overview
Table 99. Hologic Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 100. Hologic Recent Development
Table 101. Illumina Company Details
Table 102. Illumina Business Overview
Table 103. Illumina Molecular Diagnosis and Therapy Product
Table 104. Illumina Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 105. Illumina Recent Development
Table 106. Qiagen Company Details
Table 107. Qiagen Business Overview
Table 108. Qiagen Molecular Diagnosis and Therapy Product
Table 109. Qiagen Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 110. Qiagen Recent Development
Table 111. Roche Diagnostics Company Details
Table 112. Roche Diagnostics Business Overview
Table 113. Roche Diagnostics Molecular Diagnosis and Therapy Product
Table 114. Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 115. Roche Diagnostics Recent Development
Table 116. Siemens AG Company Details
Table 117. Siemens AG Business Overview
Table 118. Siemens AG Molecular Diagnosis and Therapy Product
Table 119. Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 120. Siemens AG Recent Development
Table 121. Thermo Fisher Scientific Company Details
Table 122. Thermo Fisher Scientific Business Overview
Table 123. Thermo Fisher Scientific Molecular Diagnosis and Therapy Product
Table 124. Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2016-2021) & (US$ Million)
Table 125. Thermo Fisher Scientific Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnosis and Therapy Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. DNA Sequencing Features
Figure 4. NGS Features
Figure 5. Global Molecular Diagnosis and Therapy Market Share by Application: 2020 VS 2027
Figure 6. Diagnostic Laboratories Case Studies
Figure 7. Research & Academic Laboratories Case Studies
Figure 8. Molecular Diagnosis and Therapy Report Years Considered
Figure 9. Global Molecular Diagnosis and Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Molecular Diagnosis and Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Molecular Diagnosis and Therapy Market Share by Regions: 2020 VS 2027
Figure 12. Global Molecular Diagnosis and Therapy Market Share by Regions (2022-2027)
Figure 13. Global Molecular Diagnosis and Therapy Market Share by Players in 2020
Figure 14. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis and Therapy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Molecular Diagnosis and Therapy Revenue in 2020
Figure 16. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2016-2021)
Figure 17. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2022-2027)
Figure 18. North America Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Molecular Diagnosis and Therapy Market Share by Type (2016-2027)
Figure 20. North America Molecular Diagnosis and Therapy Market Share by Application (2016-2027)
Figure 21. North America Molecular Diagnosis and Therapy Market Share by Country (2016-2027)
Figure 22. United States Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Molecular Diagnosis and Therapy Market Share by Type (2016-2027)
Figure 26. Europe Molecular Diagnosis and Therapy Market Share by Application (2016-2027)
Figure 27. Europe Molecular Diagnosis and Therapy Market Share by Country (2016-2027)
Figure 28. Germany Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Molecular Diagnosis and Therapy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Molecular Diagnosis and Therapy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Molecular Diagnosis and Therapy Market Share by Region (2016-2027)
Figure 38. China Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Molecular Diagnosis and Therapy Market Share by Type (2016-2027)
Figure 46. Latin America Molecular Diagnosis and Therapy Market Share by Application (2016-2027)
Figure 47. Latin America Molecular Diagnosis and Therapy Market Share by Country (2016-2027)
Figure 48. Mexico Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Molecular Diagnosis and Therapy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Molecular Diagnosis and Therapy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Molecular Diagnosis and Therapy Market Share by Country (2016-2027)
Figure 54. Turkey Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Molecular Diagnosis and Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 58. Agilent Technologies Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 59. Becton, Dickinson and Company Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 60. Biomérieux Sa Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 61. Danaher Corporation Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 62. Diasorin Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 63. Grifols Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 64. Hologic Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 65. Illumina Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 66. Qiagen Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 67. Roche Diagnostics Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 68. Siemens AG Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 69. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…- 世界の精巣がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing testicular Cancer Market Analysis and Insights: Global Molecular Diagnosis of Testicular Cancer Market The global Molecular Diagnosis of Testicular Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% durin…
- 世界の結核分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing tuberculosis Market Analysis and Insights: Global Molecular Diagnosis of Tuberculosis Market The global Molecular Diagnosis of Tuberculosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. Wi…
- 世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年） A diagnostic method for myelodysplastic syndrome Market Analysis and Insights: Global Molecular Diagnosis of Myelodysplastic Syndrome Market The global Molecular Diagnosis of Myelodysplastic Syndrome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of …
- 世界の胆嚢がん分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing gallbladder cancer Market Analysis and Insights: Global Molecular Diagnosis of Gallbladder Cancer Market The global Molecular Diagnosis of Gallbladder Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-20…